Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Wrzesiński, Tomasz ^a   Szelag, Malgorzata ^a   Cieślikowski, Wojciech A ^b   Ida, Agnieszka ^b   Giles, Rachel ^c   Zodro, Elzbieta ^a   Szumska, Joanna ^a   ź, Joanna ^a   Kwias, Zbigniew ^b   Bluyssen, Hans A R ^a   Wesoly, Joanna ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bioinformatics; ccRCC; ER; Gene expression; Transmembrane proteins

Indexed keywords

MEMBRANE PROTEIN; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BIOINFORMATICS; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; FEMALE; GENE; GENE LOCATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PATHOGENESIS; PROSPECTIVE STUDY; QUALITATIVE RESEARCH; REAL TIME POLYMERASE CHAIN REACTION; RTP3 GENE; SLC35G2 GENE; TMEM GENE; TMEM116 GENE; TMEM207 GENE; TMEM213 GENE; TMEM30B GENE; TMEM45A GENE; TMEM45B GENE; TMEM61 GENE; TMEM72 GENE; AGED; BIOLOGY; CANCER GRADING; CLUSTER ANALYSIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; MULTIGENE FAMILY; ODDS RATIO; PATHOLOGY; PROTEIN TRANSPORT; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIGENE FAMILY; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; ODDS RATIO; PROTEIN TRANSPORT; RECEPTORS, ESTROGEN; TUMOR BURDEN;

EID: 84937027239     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1530-4     Document Type: Article

References (84)

1. Rydzanicz M, Wrzesinski T, Bluyssen HA, Wesoly J. Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications. Cancer Lett. 2013;341(2):111-26.
2. Rechsteiner MP, von Teichman A, Nowicka A, Sulser T, Schraml P, Moch H. VHL gene mutations and their effects on hypoxia inducible factor HIFalpha: identification of potential driver and passenger mutations. Cancer Res. 2011;71(16):5500-11.
3. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176(6 Pt 1):2353-8.
4. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol. 2004;22(24):4991-5004.
5. Nelson EC, Evans CP, Lara Jr PN. Renal cell carcinoma: current status and emerging therapies. Cancer Treat Rev. 2007;33(3):299-313.
6. Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2007;28(2):143-9.
7. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A. 2001;98(17):9754-9.
8. Sato Y, Yoshizato T, Shiraishi Y, Maekawa S, Okuno Y, Kamura T, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013;45(8):860-7.
9. Cuajungco MP, Podevin W, Valluri VK, Bui Q, Nguyen VH, Taylor K. Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology. Acta Histochem. 2012;114(7):705-12.
10. Hrasovec S, Hauptman N, Glavac D, Jelenc F, Ravnik-Glavac M. TMEM25 is a candidate biomarkermethylated and down-regulated in colorectal cancer. Dis Markers. 2013;34(2):93-104
11. Perez-Magan E, Campos-Martin Y, Mur P, Fiano C, Ribalta T, et al. Genetic alterations associated with progression and recurrence in meningiomas. J Neuropathol Exp Neurol. 2012;71(10):882-93.
12. Abermil N, Guillaud-Bataille M, Burnichon N, Venisse A, Manivet P, Guignat L, et al. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma. J Clin Endocrinol Metab. 2012;97(5):E805-9.
13. Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, et al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 2009;69(11):4674-81.
14. Cifola I, Spinelli R, Beltrame L, Peano C, Fasoli E, Ferrero S, et al. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer. 2008;7:6.
15. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, et al. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007;13(16):4740-9.
16. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, et al. Gene signatures of progression and metastasis in renal cell cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005;11(16):5730-9.
17. Tun HW, Marlow LA, von Roemeling CA, Cooper SJ, Kreinest P, Wu K, et al. Pathway signature and cellular differentiation in clear cell renal cell carcinoma. PLoS One. 2010;5(5), e10696.
18. Wang Y, Roche O, Yan MS, Finak G, Evans AJ, Metcalf JL, et al. Regulation of endocytosis via the oxygen-sensing pathway. Nat Med. 2009;15(3):319-24.
19. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature. 2010;463(7279):360-3.
20. Zodro E, Jaroszewski M, Ida A, Wrzesinski T, Kwias Z, Bluyssen H, Wesoly J. FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data. Tumour Biol. 2014;35(3):2607-17
21. Fuller CM. Time for TMEM? J Physiol. 2012;590(Pt 23):5931-2.
22. Ma F, Zhang C, Prasad KV, Freeman GJ, Schlossman SF. Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death. Proc Natl Acad Sci U S A. 2001;98(17):9778-83.
23. Foulquier F, Amyere M, Jaeken J, Zeevaert R, Schollen E, Race V, et al. TMEM165 deficiency causes a congenital disorder of glycosylation. Am J Hum Genet. 2012;91(1):15-26.
24. Carette JE, Guimaraes CP, Varadarajan M, Park AS, Wuethrich I, Godarova A, et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science. 2009;326(5957):1231-5.
25. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455(7213):674-8.
26. Kholodnyuk ID, Kozireva S, Kost-Alimova M, Kashuba V, Klein G, Imreh S. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer. 2006;119(1):99-107.
27. Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, et al. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res. 2005;65(11):4817-26.
28. Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, et al. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol. 2006;29(4):799-827.
29. Dobashi S, Katagiri T, Hirota E, Ashida S, Daigo Y, Shuin T, et al. Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells. Oncol Rep. 2009;21(2):305-12.
30. R: A language and environment for statistical computing. R Foundation for Statistical Computing [ http://www.R-project.org/ ]
31. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716-23.
32. leaps: regression subset selection. R package version 2.9 [ http://CRAN.R-project.org/package=leaps ]
33. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J stat softw. 2010;33(1):1-22.
34. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J stat softw. 2010;33(1):1.
35. O'brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673-90.
36. Gray RJ. Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis. J Am Stat Assoc. 1992;87(420):942-51.
37. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis: Springer. 2001. http://link.springer.com/book/10.1007%2F978-1-4757-3462-1
38. Le Cessie S, Van Houwelingen J. Ridge estimators in logistic regression. Appl stat. 1992;191-201.
39. Verweij PJ, Van Houwelingen HC. Penalized likelihood in cox regression. Stat Med. 1994;13(23-24):2427-36.
40. Verweij PJ, van Houwelingen HC. Time-dependent effects of fixed covariates in Cox regression. Biometrics. 1995;1550-1556.
41. Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox's proportional hazards model via coordinate descent. J stat softw. 2011;39(5):1-13.
42. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-26.
43. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;289-300.
44. Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, et al. Pfam: the protein families database. Nucleic Acids Res. 2014;42(Database issue):D222-30.
45. Kurowski MA, Bujnicki JM. GeneSilico protein structure prediction meta-server. Nucleic Acids Res. 2003;31(13):3305-7.
46. Wallner B, Elofsson A. Pcons5: combining consensus, structural evaluation and fold recognition scores. Bioinformatics. 2005;21(23):4248-54.
47. Nakai K, Kanehisa M. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics. 1992;14(4):897-911.
48. McGeoch DJ. On the predictive recognition of signal peptide sequences. Virus Res. 1985;3(3):271-86.
49. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 1986;14(11):4683-90.
50. Singer SJ. The structure and insertion of integral proteins in membranes. Annu Rev Cell Biol. 1990;6:247-96.
51. Klein P, Kanehisa M, DeLisi C. The detection and classification of membrane-spanning proteins. Biochim Biophys Acta. 1985;815(3):468-76.
52. Reinhardt A, Hubbard T. Using neural networks for prediction of the subcellular location of proteins. Nucleic Acids Res. 1998;26(9):2230-6.
53. McNew JA, Goodman JM. The targeting and assembly of peroxisomal proteins: some old rules do not apply. Trends Biochem Sci. 1996;21(2):54-8.
54. Teasdale RD, Jackson MR. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu Rev Cell Dev Biol. 1996;12:27-54.
55. Stack JH, Horazdovsky B, Emr SD. Receptor-mediated protein sorting to the vacuole in yeast: roles for a protein kinase, a lipid kinase and GTP-binding proteins. Annu Rev Cell Dev Biol. 1995;11:1-33.
56. Horton P, Nakai K. Better prediction of protein cellular localization sites with the k nearest neighbors classifier. Proceedings / International Conference on Intelligent Systems for Molecular Biology; ISMB International Conference on Intelligent Systems for Molecular Biology. 1997;5:147-52.
57. Lee S, Lee B, Jang I, Kim S, Bhak J. Localizome: a server for identifying transmembrane topologies and TM helices of eukaryotic proteins utilizing domain information. Nucleic acids res. 2006;34:W99-103. Web Server issue.
58. Kall L, Krogh A, Sonnhammer EL. A combined transmembrane topology and signal peptide prediction method. J Mol Biol. 2004;338(5):1027-36.
59. Buck-Koehntop BA, Mascioni A, Buffy JJ, Veglia G. Structure, dynamics, and membrane topology of stannin: a mediator of neuronal cell apoptosis induced by trimethyltin chloride. J Mol Biol. 2005;354(3):652-65.
60. Collart MA, Struhl K. CDC39, an essential nuclear protein that negatively regulates transcription and differentially affects the constitutive and inducible HIS3 promoters. EMBO J. 1993;12(1):177-86.
61. Takatsu H, Baba K, Shima T, Umino H, Kato U, Umeda M, et al. ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner. J Biol Chem. 2011;286(44):38159-67.
62. Clarke HJ, Chambers JE, Liniker E, Marciniak SJ. Endoplasmic reticulum stress in malignancy. Cancer Cell. 2014;25(5):563-73.
63. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7(2):79-94.
64. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A. 2006;103(35):13132-7.
65. Mehrle A, Rosenfelder H, Schupp I, del Val C, Arlt D, Hahne F, et al. The LIFEdb database in 2006. Nucleic Acids Res. 2006;34(Database issue):D415-8.
66. Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S. Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 2000;1(3):287-92.
67. Ishida N, Kawakita M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch: Eur j physiol. 2004;447(5):768-75.
68. Wang AG, Yoon SY, Oh JH, Jeon YJ, Kim M, Kim JM, et al. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun. 2006;345(3):1022-32.
69. Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K, Ushijima T. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res. 2006;66(12):6080-6.
70. Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, et al. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol. 2012;14(10):1089-98.
71. Wang J, Huo K, Ma L, Tang L, Li D, Huang X, et al. Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011;7:536.
72. Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res. 2012;72(17):4574-86.
73. Molina-Pinelo S, Gutierrez G, Pastor MD, Hergueta M, Moreno-Bueno G, Garcia-Carbonero R, et al. MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer. PLoS One. 2014;9(3), e90524.
74. Paulo P, Ribeiro FR, Santos J, Mesquita D, Almeida M, Barros-Silva JD, et al. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements. Neoplasia. 2012;14(7):600-11.
75. Xie P, Kondeti VK, Lin S, Haruna Y, Raparia K, Kanwar YS. Role of extracellular matrix renal tubulo-interstitial nephritis antigen (TINag) in cell survival utilizing integrin (alpha)vbeta3/focal adhesion kinase (FAK)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B-serine/threonine kinase (AKT) signaling pathway. J Biol Chem. 2011;286(39):34131-46.
76. Billingsley ML, Yun J, Reese BE, Davidson CE, Buck-Koehntop BA, Veglia G. Functional and structural properties of stannin: roles in cellular growth, selective toxicity, and mitochondrial responses to injury. J Cell Biochem. 2006;98(2):243-50.
77. Davidson CE, Reese BE, Billingsley ML, Yun JK. Stannin, a protein that localizes to the mitochondria and sensitizes NIH-3 T3 cells to trimethyltin and dimethyltin toxicity. Mol Pharmacol. 2004;66(4):855-63.
78. Behrens M, Bartelt J, Reichling C, Winnig M, Kuhn C, Meyerhof W. Members of RTP and REEP gene families influence functional bitter taste receptor expression. J Biol Chem. 2006;281(29):20650-9.
79. Kiss H, Yang Y, Kiss C, Andersson K, Klein G, Imreh S, et al. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. European journal of human genetics : EJHG. 2002;10(1):52-61.
80. Lahiri SK, Zhao J. Kruppel-like factor 8 emerges as an important regulator of cancer. Am j transl res. 2012;4(3):357-63.
81. Varrault A, Ciani E, Apiou F, Bilanges B, Hoffmann A, Pantaloni C, et al. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc Natl Acad Sci U S A. 1998;95(15):8835-40.
82. Zhou X, Popescu NC, Klein G, Imreh S. The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Cancer Genet Cytogenet. 2007;177(1):6-15.
83. Duivenvoorden WC, Paschos A, Hopmans SN, Austin RC, Pinthus JH. Endoplasmic reticulum protein ERp46 in renal cell carcinoma. PLoS One. 2014;9(3), e90389.
84. von Roemeling CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR, Wu K, et al. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013;19(9):2368-80.